Profound Medical (PRN) Stock Statistics & Valuation Metrics

Profound Medical has a market cap or net worth of C$345.57M. The enterprise value is C$164.89M.

Profound Medical has 36,337,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.11%.

The current PE Ratio of Profound Medical is ―. Profound Medical’s PEG ratio is -0.27.

In the last 12 months, Profound Medical had revenue of 16.38M and earned -43.32M in profits. Earnings per share was -1.43.

In the last 12 months, operating cash flow was -40.81M and capital expenditures -245.93K, giving a free cash flow of -41.06M billion.

Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Profound Medical upcoming earnings date is Jul 30, 2026, After Close (Confirmed).

Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 12.56%

In the past 12 months, Profound Medical has paid 256.41K in taxes.

Profound Medical EV to EBITDA ratio is -6.54, with an EV/FCF ratio of -6.93.

Profound Medical has C$50.33M in cash and marketable securities with C$7.47M in debt, giving a net cash position of C$42.86M billion.

Gross margin is 70.58%, with operating margin of -256.27%, and net profit margin of -264.44%.

The average price target for Profound Medical is C$15.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy